Grant Zeng, CFA
Research analyst, CFA, biotech, small-cap

Sorrento Therapeutics: Has The Potential To Become Next Abraxis

Sorrento Therapeutics (NASDAQ:SRNE) is a development stage biopharmaceutical company focused on the development and commercialization of proprietary drug therapeutics for cancer and cancer pain. The company is also developing therapeutic products for other indications, including inflammation, metabolic disorders, and infectious diseases.

Sorrento's pipeline consists of lead oncology product candidate Cynviloq™, a polymeric micellar nanoparticle paclitaxel formulation, resiniferatoxin (RTX), a non-opiate, ultra potent and selective agonist of the TRPV-1 receptor for cancer pain, as well as fully human therapeutic antibodies derived from its proprietary G-MAB® library platform and antibody drug conjugates (ADCs).

(click to enlarge)(click to enlarge)

Cynviloq, Next Generation of Abraxane®

Cynviloq is Sorrento's lead cancer drug candidate. Cynviloq™ is a next-generation nanoparticle

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
PRO Top long ideas returned 21.7% in 2016**
"As a PRO member, we get uniquely valuable perspective that go beyond our quantiative analysis... We rely on PRO to get beyond the numbers quickly and add much needed perspective. It keeps me ahead of the next big thing. - Mark Choate, Malaga Cove Capital"
Mark Choate, Malaga Cove Capital
"Contributors (writers and commentators), often have a long history in the secuirities they opine on and some are clearly well positioned industry participants with detailed industry views that can help provide color on where the skeletons are buried in a particular secuirity and/or industry."
Jim Roumell, Roumell Asset Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details